Literature DB >> 32373244

Management of a patient presenting with giant cell myocarditis - A case report.

Nisarg Patel1, Nishank Nooli1, Linda Sundt1.   

Abstract

Giant cell myocarditis is a rare and frequently fatal disease that requires extensive cardiac care. Given the rarity of this condition no specific management recommendations exist. We describe a patient who presented with congestive heart failure that required a left ventricular assist device and a temporary right ventricular assist device along with immunosuppressive therapy. This case also brings to attention how undocumented immigration status can limit transplantation opportunities in the USA. <Learning objective: Giant cell myocarditis is a rare and frequently fatal cardiac disease that, until the 1980s, was only diagnosed during autopsy. It is commonly seen in young and middle-aged, otherwise healthy, individuals with median transplant-free survival of 5.5 months from diagnosis. Current treatments with immunosuppressant medications do not seem to be significantly effective. Most patients require transplant or ventricular assist device for survival.>.
© 2020 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Giant cell myocarditis; Heart failure; Heart transplantation; Left ventricular assist device

Year:  2020        PMID: 32373244      PMCID: PMC7195568          DOI: 10.1016/j.jccase.2020.01.007

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  1 in total

1.  Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation.

Authors:  Yevgeniy Brailovsky; Amirali Masoumi; Rachel Bijou; Estefania Oliveros; Gabriel Sayer; Koji Takeda; Nir Uriel
Journal:  JACC Case Rep       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.